Eagle Capital Management, LLC Amgen Inc Transaction History

Eagle Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 19, 2018	SELL	$166.05 - $186.51 $2.75 Million - $3.09 Million	-16,578 Closed	0 $0
Q1 2018 Apr 09, 2018	SELL	$169.43 - $198.0 $70,652 - $82,566	-417 Reduced 2.45%	16,578 $2.83 Million
Q4 2017 Jan 19, 2018	SELL	$168.79 - $188.59 $3,544 - $3,960	-21 Reduced 0.12%	16,995 $2.96 Million
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $2.85 Million - $3.25 Million	17,016	17,016 $3.17 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Eagle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Capital Management, LLC with notifications on news.